Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Intelligent Bio Solutions Inc.

INBS
Current price
2.19 USD -0.27 USD (-10.98%)
Last closed 2.48 USD
Company gbs.inc
ISIN unknown
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 6 234 100 USD
Yield for 12 month -86.38 %
1Y
3Y
5Y
10Y
15Y
INBS
21.11.2021 - 28.11.2021

Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. operates as a subsidiary of Life Science Biosensor Diagnostics Pty Ltd. Address: 142 West 57th Street, New York, NY, United States, 10019

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

12 USD

P/E ratio

Dividend Yield

Current Year

+1 256 872 USD

Last Year

Current Quarter

+823 800 USD

Last Quarter

+764 063 USD

Current Year

+326 668 USD

Last Year

Current Quarter

-140 434 USD

Last Quarter

+199 248 USD

Key Figures INBS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -9 253 270 USD
Operating Margin TTM -358.55 %
PE Ratio
Return On Assets TTM -45.62 %
PEG Ratio
Return On Equity TTM -118.96 %
Wall Street Target Price 12 USD
Revenue TTM 2 827 092 USD
Book Value 3.82 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 80.2 %
Dividend Yield
Gross Profit TTM 326 668 USD
Earnings per share -29.56 USD
Diluted Eps TTM -29.56 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics INBS

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History INBS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:12
Payout Ratio
Last Split Date 29.01.2024
Dividend Date

Stock Valuation INBS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 4.4584
Price Sales TTM 2.2051
Enterprise Value EBITDA -0.9103
Price Book MRQ 0.56

Financials INBS

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators INBS

For 52 weeks

1 USD 16.44 USD
50 Day MA 1.46 USD
Shares Short Prior Month 85 286
200 Day MA 2.89 USD
Short Ratio 1.63
Shares Short 169 990
Short Percent 5.46 %